These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 9885511

  • 1. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
    Koch A, Kothe H, Braun J, Kämmerer R, Friedrich HJ, Dalhoff K.
    Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
    [Abstract] [Full Text] [Related]

  • 2. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
    Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, Nielsen TL, van der Graaf Y, Frissen JP, van der Ende IM, Kolsters AF, Borleffs JC.
    N Engl J Med; 1992 Dec 24; 327(26):1836-41. PubMed ID: 1360145
    [Abstract] [Full Text] [Related]

  • 3. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
    Mallolas J, Zamora L, Gatell JM, Miró JM, Vernet E, Valls ME, Soriano E, SanMiguel JG.
    AIDS; 1993 Jan 24; 7(1):59-64. PubMed ID: 8442918
    [Abstract] [Full Text] [Related]

  • 4. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE, Keruly J, Richman DD, Moore RD.
    Arch Intern Med; 1992 Oct 24; 152(10):2009-13. PubMed ID: 1417373
    [Abstract] [Full Text] [Related]

  • 5. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM, Landman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, Gaudebout C, Certain A, Boué F, Bouvet E.
    N Engl J Med; 1993 May 27; 328(21):1514-20. PubMed ID: 8479488
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
    Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ.
    N Engl J Med; 1992 Dec 24; 327(26):1842-8. PubMed ID: 1448121
    [Abstract] [Full Text] [Related]

  • 9. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C, Pezzotti P, Govoni A, Borghi V, Antinori A, d'Arminio Monforte A, De Luca A, Mongiardo N, Cerri MC, Chiodo F, Concia E, Bonazzi L, Moroni M, Ortona L, Esposito R, Cossarizza A, De Rienzo B.
    J Infect Dis; 2000 May 24; 181(5):1635-42. PubMed ID: 10823763
    [Abstract] [Full Text] [Related]

  • 10. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.
    Chan C, Montaner J, Lefebvre EA, Morey G, Dohn M, McIvor RA, Scott J, Marina R, Caldwell P.
    J Infect Dis; 1999 Aug 24; 180(2):369-76. PubMed ID: 10395851
    [Abstract] [Full Text] [Related]

  • 11. [Primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol. Effectiveness, side effects and incidence of extrapulmonary Pneumocystis carinii manifestations].
    Stoehr A, Plettenberg A, Albrecht H, Stellbrink HJ, Meigel W, Begemann F.
    Med Klin (Munich); 1994 Mar 15; 89(3):132-5. PubMed ID: 8196573
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, van der Horst C, Feinberg J.
    N Engl J Med; 1995 Mar 16; 332(11):693-9. PubMed ID: 7854375
    [Abstract] [Full Text] [Related]

  • 13. [Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
    Groll AH, Ritter J, Müller FM.
    Klin Padiatr; 2001 Sep 16; 213 Suppl 1():A38-49. PubMed ID: 11577363
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T.
    Bone Marrow Transplant; 1999 Oct 16; 24(8):897-902. PubMed ID: 10516703
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D, Bergmann F, Albrecht H, Padberg J, Wünsche T, Grünewald T, Schürmann M, Grobusch M, Vallée M, Ruf B, Suttorp N.
    Eur J Clin Microbiol Infect Dis; 2002 May 16; 21(5):353-61. PubMed ID: 12072919
    [Abstract] [Full Text] [Related]

  • 17. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
    Hibberd PL, Tolkoff-Rubin NE, Doran M, Delvecchio A, Cosimi AB, Delmonico FL, Auchincloss H, Rubin RH.
    Online J Curr Clin Trials; 1992 Aug 11; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    El-Sadr WM, Luskin-Hawk R, Yurik TM, Walker J, Abrams D, John SL, Sherer R, Crane L, Labriola A, Caras S, Pulling C, Hafner R.
    Clin Infect Dis; 1999 Oct 11; 29(4):775-83. PubMed ID: 10589887
    [Abstract] [Full Text] [Related]

  • 19. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B, Mocroft A, Reiss P, Furrer H, Kirk O, Bickel M, Uberti-Foppa C, Pradier C, D'Arminio Monforte A, Schneider MM, Lundgren JD, Eight European Study Groups.
    N Engl J Med; 2001 Jan 18; 344(3):168-74. PubMed ID: 11188837
    [Abstract] [Full Text] [Related]

  • 20. [Cerebral toxoplasmosis in HIV infected patients intolerant of cotrimoxazole].
    Rabaud C, May T, Beuscart C, Reynes J, Leport C, Canton P.
    Ann Med Interne (Paris); 1998 Mar 18; 149(2):62-6. PubMed ID: 11490526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.